Skip to main content
Log in

Project honeybee: Clinical applications for wearable biosensors

Biomedical Microdevices Aims and scope Submit manuscript

Cite this article

A Correction to this article was published on 12 September 2020

This article has been updated


Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references. The Project Honeybee Observational Clinical Trials were 12-month studies designed to validate the use of commercially available ambulatory medical devices costing $50–$300 for clinical applications. Each trial had a patient population of about 15–30 subjects with a broad range of disease types including heart failure, diabetes, sepsis, and Parkinson’s disease. Over 30 supported proposals were funded in the 4-year period, as well as the creation of a database of all commercially available devices. Each year a call for proposals was published within ASU and Mayo Clinic Arizona. Proposals were selected for funding by a committee of ASU faculty from engineering, nursing, and exercise physiology departments. The progress of each research trial was monitored through monthly colloquia with the nursing, biomedical engineering, computer science, and nutrition graduate research assistants, to discuss the challenges and opportunities arising with each research trial. PIs were required to report on study progress 6 months into the trial period and 3 months following the conclusion of the 12-month project. The project was very successful in meeting our goals of testing consumer wearable devices on patients for a variety of conditions across a variety of clinical settings in the greater Phoenix community. The following clinical sites participated in one or more of these clinical trials: Adelante Healthcare, Arizona Arrhythmia Consultants, Arizona Cardiology Group, Banner University Medical Center, Barrow Neurological Institute, Honor Health, Mayo Clinic, and St Joseph’s Hospital. A total of 12 ASU faculty and 39 clinicians participated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Change history

  • 12 September 2020

    The original version of this article unfortunately contained a mistake.


  • Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br. J. Nutr. 65(2):105–114 (1991)

    Article  Google Scholar 

Download references


The authors and all participants wish to acknowledge the generous support from the Strategic Investment Fund, Arizona State University.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Jeffrey T. La Belle.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hartwell, L., Ross, H.M. & La Belle, J.T. Project honeybee: Clinical applications for wearable biosensors. Biomed Microdevices 21, 37 (2019).

Download citation

  • Published:

  • DOI: